Previous close | 7.38 |
Open | 6.80 |
Bid | 6.95 |
Ask | 8.15 |
Strike | 52.00 |
Expiry date | 2024-05-03 |
Day's range | 6.48 - 7.38 |
Contract range | N/A |
Volume | |
Open interest | N/A |
PRINCETON, N.J., May 06, 2024--U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Application for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 06, 2024--European Medicines Agency Validates Bristol Myers Squibb’s Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line....
It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...